Digest Network Come funziona
Network
/
Società
Si
Non verificato

Silence Therapeutics plc

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaMedicina - VarieSalute

30 comunicati stampa

Guarda tutti i comunicati
12/08/2026
Associazioni/Professionisti
Salute
Finanza
Sanità
Farmaceutica
Biotecnologia
Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering
Fonte
Silence Therapeutics plc
Emittente
Business Wire
1.00
0
10/08/2026
Finanza
Biotecnologia
Salute
Medicina - Varie
Silence Therapeutics Announces Proposed Public Offering of $150 Million of American Depositary Shares
Fonte
Silence Therapeutics plc
Emittente
Business Wire
1.00
0
10/08/2026
Industria
Finanza
Web e Social Network
Telefonia e Varie
Cardiologia
Biotecnologia
Farmaceutica
Oncologia
Salute
Igiene alimentare
Medicina - Varie
Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile
Fonte
Silence Therapeutics plc
Emittente
Business Wire
1.00
0
10/08/2026
Mercato azionario
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Silence Therapeutics Reports Second Quarter 2026 Financial and Business Results
Fonte
Silence Therapeutics plc
Emittente
Business Wire
1.00
0
09/08/2026
Web e Social Network
Telefonia e Varie
Industria
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Silence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera
Fonte
Silence Therapeutics plc
Emittente
Business Wire
1.00
0
11/06/2026
Eventi
Industria
Cardiologia
Biotecnologia
Farmaceutica
Oncologia
Salute
Igiene alimentare
Medicina - Varie
Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera
Fonte
Silence Therapeutics plc
Emittente
Business Wire
1.00
0
27/05/2026
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Eventi
Web e Social Network
Silence Therapeutics to Participate in Jefferies Global Healthcare Conference
Fonte
Silence Therapeutics plc
Emittente
Business Wire
1.00
0
12/05/2026
Eventi
Web e Social Network
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Silence Therapeutics to Participate in H.C. Wainwright BioConnect Investor Conference
Fonte
Silence Therapeutics plc
Emittente
Business Wire
1.00
0
07/05/2026
Eventi
Mercato azionario
Salute
Biotecnologia
Sanità
Medicina - Varie
Farmaceutica
Silence Therapeutics Highlights Recent Business Achievements and Reports First Quarter 2026 Financial Results
Fonte
Silence Therapeutics plc
Emittente
Business Wire
1.00
0
05/03/2026
Mercato azionario
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Silence Therapeutics Highlights Recent Business Achievements and Reports Fourth Quarter and Full Year 2025 Financial Results
Fonte
Silence Therapeutics plc
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0